Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
28
Frequently Asked Questions
What is Market Cap of Oruka Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Oruka Therapeutics Inc. market cap is $604.83M.
What is the 52-week high for Oruka Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Oruka Therapeutics Inc. 52 week high is $31.13 as of September 12, 2025.
What is the 52-week low for Oruka Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Oruka Therapeutics Inc. 52 week low is $5.49 as of September 12, 2025.
What is Oruka Therapeutics Inc. stock price today?
Oruka Therapeutics Inc. stock price today is $15.39.
What was Oruka Therapeutics Inc. stock price yesterday?
Oruka Therapeutics Inc. stock price yesterday was $16.15.
What is the PE ratio of Oruka Therapeutics Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Oruka Therapeutics Inc.’s P/E ratio is -4.44.
What is the Price-to-Book ratio of Oruka Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Oruka Therapeutics Inc. P/B ratio is 1.7752.
What is the 50-day moving average of Oruka Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Oruka Therapeutics Inc. 50-day moving average is $14.52.
How many employess does Oruka Therapeutics Inc. has?